Loading clinical trials...
Loading clinical trials...
Long Term Sequelae of COVID-19: Observational Cohort Study in Twente, the Netherlands
COVID-19, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, has a devastating effect on human lives, including over 6.6 million death as of November 2022. Furthermore, many individuals continue to experience persisting sequelae after the initial infection. Little is known about the impact of undergoing COVID-19 hospitalisation. Hence, the investigators propose an observational longitudinal study in a cohort of COVID-19 survivors after hospital discharge, to examine their perspectives on their health, health-related quality of life, and persistence of common COVID-19 symptoms, such as fatigue, dyspnoea and anxiety. Potential influencing socio-demographic and biological factors will additionally assessed.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Medisch Spectrum Twente
Enschede, Overijssel, Netherlands
Start Date
July 28, 2020
Primary Completion Date
October 1, 2023
Completion Date
November 1, 2023
Last Updated
November 25, 2024
835
ACTUAL participants
Observational patient reported outcomes
OTHER
Lead Sponsor
Medisch Spectrum Twente
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06631287